CDKN1A and medulloblastoma: In vitro study has demonstrated that VPA induces histone (H3 and H4) hyperacetylation, activates p21, restore p16/CDK4 pathway and suppresses CMYC oncogene in medulloblastoma (DAOY and D283-MED) cell lines (Li et al., 2005).